Articles | Lectures | Decisions | Press Releases
 
Articles

Ask the Expert: Concerns About Patent Rule Changes, Electronic Business by Edward Weisz, Partner

Ask the Expert: Did Broadcom act unethically concerning Bluetooth?, Electronic Business by Alfred Froehbrich, Partner

Ask the Expert: Is it Better to Brand or Patent IP?, Electronic Business by Edward Weisz, Partner

Biosimilars in the United States - a Brief Look at Where We Are and the Road Ahead, Biotechnology Law Report - Expert Analysis of Current Developments by Alan J. Morrison, Partner

Business Methods and Software Patents in the United States, Peking University Intellectual Property Review, Vol. 2, p. 350 by Edward Weisz, Partner & Roger Thompson, Associate

Commentary: Supreme Court Update - KSR v. Teleflex and the Determination of Obviousness, by Alfred Froebrich, Partner & Alan Morrison, Partner

Das US-Gesetz ueber Arzneimittelpreiswettbewerb und Patent ..., Teil I, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner

Das US-Gesetz ueber Arzneimittelpreiswettbewerb und Patent ..., Teil II, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner

The Drug Price Competition and Patent Term Restoration Act - 10 Years Later, Part I, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner

The Drug Price Competition and Patent Term Restoration Act - 10 Years Later, Part II, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner

How Seagate has reshaped patent litigation practices, Managing Intellectual Property by William Alper, Partner

Intellectual Property: Six Steps for Protecting Your Trade Secrets, Big Ideas for Small Business with Edward Reisner, Senior Counsel

International Briefing - How to Avoid Errors of Inventorship, Managing Intellectual Property by Lisa A. Ferrari, Partner

International Briefing - How to Determine and Correct Inventorship, Managing Intellectual Property by Edward Weisz, Partner, and Mher Hartoonian, Associate

International Briefing - Keep It Candid at the USPTO, Managing Intellectual Property by William A. Alper, Partner

IP101: How to Legally Protect Your Semiconductor Products, Electronic Business by Thomas Langer, Partner

IP Expert Advice: How do I track the status of a patent if the company is defunct?, EDN-Electronic Business by Edward Weisz, Partner

IP Expert Advice: How to determine and correct inventorship in U.S. patents, EDN-Electronic Business by Edward Weisz, Partner & Mher Hartoonian, Associate

IP Expert Advice: Tips on creating a lab notebook that contains "convincing evidence", EDN-Electronic Business by Lance Lieberman, Partner

IP Expert Advice: U.S. inventorship and priority disputes over geography, EDN-Electronic Business by Mher Hartoonian, Associate & Edward Weisz, Partner

Know Your Knockoffs - How patents can protect lighting manufacturers, Residential Lighting by Edward Weisz, Partner

Patents: Don't Change the Landscape Too Quickly, Bank Systems &Technology by Alan Tenenbaum, Partner

Patents for Medical Devices and Avoiding Infringement, Medical Design by Edward Weisz, Partner

Potential Competition: An Idea Whose Time Has Passed, Brooklyn Law Review by William A. Alper, Partner

Preventing Loss of Right to Patent – A Summary of U.S. Statutory Bars to Patentability, Vol 2 Peking University Intellectual Property Review by Edward Weisz, Partner & Richard Margiano, Associate

Protecting Intellectual Property, Motion System Design by Martin Pavane, Partner & Richard Margiano, Associate

Protecting Pharmaceutical Products, Processes and R&D from Competitive Challenges, Pharmaceutical Technology Magazine by Michael Stuart, Partner

Recapturing R&D Leadership - Industry Week Cover Story with Lance Lieberman, Partner

Selected Topics in U.S. Biotech Patent Law by Alan J. Morrison, Partner, presented at the Workshop on Biotechnology Patent Law, hosted by Michalski Hüttermann and Partner, Düsseldorf, Germany

Special Report: Securing Intellectual Property, Avionics by Martin Pavane, Partner & Richard Margiano, Associate

Supreme Court debates critical component, by Shanaz Mahmud, Reporter, Managing Intellectual Property with Kent Cheng, Partner

 

Lectures

Beijing Institute of Technology (Beijing, China, 2005), on U.S. trademark law by Edward Weisz, Partner

“Biosimilars in the United States: An Update”, presented at Biosimilars 2007, organized by Visiongain, London, United Kingdom, December 6, 2007 by Alan Morrison, Partner

“Drafting a Patent Application that Can Withstand Litigation,” Beijing, China by Kent Cheng, Partner

Global Plastics Environmental Conferences, Detroit, Michigan on general topics concerning U.S. patent law by Edward Weisz, Partner

“International Digital Rights Developments, Digital Rights: Protecting Your Client's Rights Under Current Regulatory & Marketplace Developments,” Association of the Bar of the City of New York by Richard Margiano

“Legal Hurdles and Strategies in Building a University Biotech Portfolio,” presented as part of the panel on Building a Strong University Biotech Patent Portfolio, held at the 2008 Life Sciences Industry Summit, Long Island, New York, by Alan Morrison, Partner

New York Law School, assisted in curriculum development and guest lectured in patent and trademark courses by Edward Weisz, Partner

Peking University, Intellectual Property Law Institute (Beijing, China, 2004 & 2005), on various U.S. patent and trademark law topics by Edward Weisz, Partner

 

Decisions

Inter parties rexamination on behalf of Gladerma R&D of Leo Pharmaceutical Products Ltd., US Patent No. 6,753,013 for TACLONEX (August 2008)

The Pomeroy Collection, LTD. v. Kirkland’s Inc. & Home Essentials & Beyond, Inc., No. SACY 08-0635; AG (US Dist. June 13, 2008).

Pharm.Res., Inc. and Par Pharm., Inc. v. Roxane Labs., Inc., U.S. Court of Appeals for the Federal Circuit, 2007-1093, - 1134 (Fed. Cir. October 26, 2007).

In re Metoprolol Succinate Patent Litigation, No. 2006-1254 (Fed. Cir. July 23, 2007).

Westrex Corp. v. New Sensor Corp., 83 U.S.P.Q.2d 1215 (T.T.A.B. May 11, 2007).

Savient Pharmaceuticals, Inc. v. Sandoz, Inc., No. 2007-1081, 2007 U.S. App. LEXIS 2800, 2007 WL 419358 (Fed. Cir. Jan. 25, 2007) (order dismissing proceeding).

Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).

Dey LP v. IVAX Pharm. Inc., 233 F.R.D. 567 (C.D. Cal. 2005).

Novartis Pharm. Corp. v. Eon Labs Mfg., Inc., 363 F.3d 1306 (Fed. Cir. 2004).

In re Les Halles De Paris J.V., 334 F.3d 1371 (Fed. Cir. 2003).

Nadel v. Isaksson, 321 F.3d 266 (2d Cir. 2003).

Well-Made Toy Mfg., Corp. v. Goffa Int'l Corp., 354 F.3d 112 (2d Cir. 2003).

Glaxo Wellcome Inc., v. Eon Labs Mfg., Inc., No. 00-Civ-9089, 2003 U.S. Dist LEXIS 14680, 2003 WL 22004874 (S.D.N.Y. Aug. 22, 2003).

In re Omeprazole Patent Litigation, 265 F. Supp. 2d 213 (S.D.N.Y. 2003).

Elite Licensing, Inc. v. Thomas Plastics, Inc., 250 F. Supp. 2d 372 (S.D.N.Y. 2003).

In re '639 Patent Litigation 154 F. Supp. 2d 157 (D. Mass. 2001), aff''d sub. nom. SmithKline Beecham Corp. v. Copley Pharm., No. 01-1611, 45 Fed. Appx. 915 (Fed. Cir. Aug. 15, 2002).

Well-Made Toy Mfg., Corp. v. Goffa Int'l Corp., 210 F. Supp. 2d 147 (E.D.N.Y. 2002).

Glaxo Wellcome Inc., v. Eon Labs Mfg., Inc., No. 00-Civ-9089, 2002 U.S. Dist. LEXIS 14950, 2002 WL 1874831 (S.D.N.Y. Aug. 13, 2002).

Bristol-Myers Squibb Co. v. Ben Venue Labs., Inc., 246 F.3d 1368 (Fed. Cir. 2001).

Nadel v. Play-By-Play Toys & Novelties, Inc., 208 F.3d 368 (2d Cir. 2000).

Ideal World Marketing Inc. v. Duracell Inc., 997 F. Supp. 334 (E.D.N.Y. 1998).

Valmet Paper Mach. Inc. v. Beloit Corp., 105 F.3d 1409 (Fed. Cir. 1997).

Thermalloy, Inc. v. Aavid Eng'g, Inc., 121 F.3d 691 (Fed. Cir. 1997).

Bayer AG v. Barr Laboratories, Inc., No. 92-Civ-0381, 1996 U.S. Dist. LEXIS 13032, 1996 WL 509714 (S.D.N.Y. 1996).

Glaxo Inc., Glaxo Group Limited, and Allen and Hanburys Limited v. Boehringer Ingelheim Corporation, and Boehringer Ingelheim Chemicals, Inc., 40 U.S.P.Q.2D 1848 (D.Conn. 1996).

Glaxo Inc., Glaxo Group Limited, and Hanburys Limited v. Boehringer Ingelheim Corporation and Boehringer Ingelheim Chemicals, Inc., 954 F. Supp. 469, 41 U.S.P.Q.2D 1445 (D.Conn. 1996).

Godinger Silver Art Co., Ltd. v. Int'l Silver Co. Inc., No. 95-Civ-9199, 1995 U.S. Dist LEXIS 17696, 1995 WL 702357 (S.D.N.Y. 1995).

Imperial Chem. Indus., PLC, v. Barr Labs., 795 F. Supp. 619 (S.D.N.Y. 1992).

Wallace Int'l Silversmiths, Inc. v. Godinger Silver Art Co., Inc., 916 F.2d 76 (2d Cir. 1990).

 

Press Releases

CPLP successfully Challenges a U.S. Patent on Behalf of Client in a USPTO Reexamination Proceeding - August 2008

Order Denying a Temporary Restraining Order and Granting an Order to Show Cause – US District Court Central District of CA Case No SACV 08-0635 AG - June 2008

Alan Tenebaum Joins Cohen Pontani Lieberman & Pavane LLP in New York City as a Partner - May 2008

Alfred W. Froebrich Named Partner at Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008

Julia S. Kim Named Partner at Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008

Lisa A Ferrari Named Partner at Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008

Marilyn Neiman Joins Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008

CPLP Alert: U.S. Patent and Trademark Office Final Rule Held Void - April 8, 2008

CPLP Alert: Implementation of the Final Rule by the USPTO has been enjoined - November 7, 2007

CPLP Partner Thomas Langer Briefs French ASPI on the Impact of New USPTO Regulations

CPLP Alert: The Final Rule and Its Effect on U.S. Patent Practice – CPLP has identified tactical approaches and outlined recommendations for complying with the USPTO “Final Rule.”

CPLP Alert: Changes to U.S. patent practice – The USPTO “Final Rule” is scheduled to become effective November 1, 2007.

Alan J. Morrison Joins Cohen Pontani Lieberman & Pavane

Back to Top